Literature DB >> 681023

Infectious mononucleosis and Hodgkin's disease.

N Muñoz, R J Davidson, B Witthoff, J E Ericsson, G De-Thé.   

Abstract

A cohort of 9,454 patients with infectious mononucleosis, serologically confirmed, was followed up to determine their risk of developing lymphoproliferative diseases. A total of 1,759 patients was identified in Scotland from 1959 to 1971 and 7,695 in Sweden from 1952 to 1970. The cancer cases were identified by matching the list of patients with infectious mononucleosis against a list of patients with lymphoma, nasopharyngeal and colon carcinomas registered through 1972 in Sweden and through 1973 in Scotland. A four-fold increase in risk was found for Hodgkin's disease based on 7 cases observed against 1.8 expected. Most of the excess cases of Hodgkin's disease occurred within three years of the diagnosis of infectious moonucleosis and among females. These results are similar to those of four other cohort studies and it is concluded that a positive association exists between infectious mononucleosis and Hodgkin's disease. Several explanations of this association were evaluated. Firstly, it may be that a very small proportion of persons who are in the course of developing Hodgkin's disease are temporarily misdiagnosed as having infectious mononucleosis. Secondly, infectious mononucleosis may increase the susceptibility to a factor which causes or promotes the development of Hodgkin's disease. Thirdly, infectious mononucleosis and Hodgkin's disease may share a common aetiology. Arguments in favour of, or against, each of these explanations are presented.

Entities:  

Mesh:

Year:  1978        PMID: 681023     DOI: 10.1002/ijc.2910220104

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  EBV-associated lymphomas in adults.

Authors:  Mark Roschewski; Wyndham H Wilson
Journal:  Best Pract Res Clin Haematol       Date:  2012-02-05       Impact factor: 3.020

Review 2.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

3.  Epstein-Barr viral DNA in tissues of Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; R A Warnke; D T Purtilo; J Sklar
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

Review 4.  Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes.

Authors:  Kieron Dunleavy; Mark Roschewski; Wyndham H Wilson
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

5.  Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice.

Authors:  Eun Kyung Lee; Eun Hye Joo; Kyung-A Song; Bongkum Choi; Miyoung Kim; Seok-Hyung Kim; Sung Joo Kim; Myung-Soo Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

6.  EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages.

Authors:  J M Edwards; M Woodroof
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

7.  T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice.

Authors:  Frank Heuts; Martin E Rottenberg; Daniel Salamon; Eahsan Rasul; Monika Adori; George Klein; Eva Klein; Noemi Nagy
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

8.  Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study.

Authors:  T Lehtinen; J Lumio; J Dillner; M Hakama; P Knekt; M Lehtinen; L Teppo; P Leinikki
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

9.  Association of Epstein-Barr virus with pediatric Hodgkin's disease.

Authors:  A A Armstrong; F E Alexander; R P Paes; N A Morad; A Gallagher; A S Krajewski; D B Jones; B Angus; J Adams; R A Cartwright
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

10.  Localization of predisposition to Hodgkin disease in the HLA class II region.

Authors:  W Klitz; C L Aldrich; N Fildes; S J Horning; A B Begovich
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.